Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, placebo-controlled, non-comparative, phase II study to
evaluate the influence of an adjuvant, intravenous therapy with zoledronic acid (single dose)
on healing after arthroscopic repair of chronic rotator cuff tears.
The study including its financial support was approved by the medical director of the General
Accident Insurance Institution (AUVA) , Dr. Roland Frank.
Hypothesis to prove: Adjuvant intravenous therapy with zoledronic acid does improve tendon
healing after arthroscopic reconstruction of chronic rotator cuff tears compared to a control
group without adjuvant therapy with zoledronic acid.,
Phase:
Phase 2
Details
Lead Sponsor:
AUVA Traumazentrum Vienna Site UKH Meidling
Collaborators:
CCSRM Clinical Center for Studies in Regenerative Medicine in cooperation with the Ludwig Boltzmann Institute for Traumatology Ludwig Boltzmann Institute for Traumatology _ The research center in cooperation with AUVA